🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, open-label, ascending-dose trial of the safety and t...
Status
Completed
Location
City of Hope
Start Date
2010-07
Trial ID
NCT01156584
Treatments Being Tested
This is a Phase 1, multicenter, open-label study of intravesical Toca 511 f...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-12
Trial ID
NCT04089163
Treatments Being Tested
This is a multicenter, randomized, open-label phase 2/3 study of Toca 511 a...
Status
Terminated
Location
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
Start Date
2015-11-30
Trial ID
NCT02414165
Treatments Being Tested
This is a multi-center, open label trial of combination therapy with Toca 5...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT02598011
This is a multicenter, open-label, continuation study to allow subjects who...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2011-02
Trial ID
NCT04327011
Treatments Being Tested
The purpose of this trial is to evaluate changes in immune activity relativ...
Status
Terminated
Location
Sarah Cannon Research Institute
Start Date
2016-07
Trial ID
NCT02576665
This is a multicenter study evaluating the safety and tolerability of Toca ...
Status
Completed
Location
UC Irivine
Start Date
2014-02
Trial ID
NCT01985256
This is a multicenter, open-label study of DB107-RRV (formerly Toca 511) an...
Status
Recruiting
Location
University of Southern California
Start Date
2025-01-08
Trial ID
NCT06504381
This is a multicenter study evaluating the safety and tolerability of incre...
Status
Completed
Location
UCLA
Start Date
2012-02
Trial ID
NCT01470794
Treatments Being Tested
This phase II/III trial studies how well vocimagene amiretrorepvec (Toca 51...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-01-31
Trial ID
NCT04105374